№ files_lp_3_process_7_072126
File format: docx Character count: 21019 File size: 71 KB
This document is a Patient Group Direction (PGD) detailing the use of oral metronidazole for the treatment of bacterial vaginosis and trichomoniasis, with specific guidelines on treatment, exclusion criteria, and governance.
Note: Version Number 2.1, October 2023
Year: 2023
Region / city: Not specified
Topic: Sexual Health, Bacterial Vaginosis, Trichomonas Vaginalis
Document Type: PGD (Patient Group Direction)
Organization: British Association for Sexual Health and HIV (BASHH)
Author: Ali Grant, Alison Crompton, Andrea Smith, and others
Target Audience: Registered healthcare professionals authorized to practice under PGDs
Effective Date: July 2023
Review Date: December 2025
Expiration Date: June 2026
Date of Approval: February 2023
Date of Last Change: October 2023
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Epidemiologic evidence on the role of Lactobacillus iners in sexually transmitted infections and bacterial vaginosis: a series of systematic reviews and meta-analyses
Year: 2023
Region / city: Seattle, WA, USA
Topic: Microbiology, Epidemiology, Infectious Diseases
Document type: Research Article
Organization / institution: University of Washington, Fred Hutchinson Cancer Research Center
Author: Kayla A. Carter, Molly D. Fischer, Mariya I. Petrova, Jennifer E. Balkus
Target audience: Researchers, Public Health Professionals
Period of validity: Not specified
Date of approval: Not specified
Date of changes: Not specified
Rifaximin and Metronidazole Fixed Dose Combination – A New Treatment Option in the Management of Diarrhea
Year: 2021
Region / City: India
Topic: Acute diarrhea, antimicrobial treatment
Document Type: Research Article
Author: Not specified
Target Audience: Medical professionals, researchers in infectious diseases
Duration: 5 days of treatment
Approval Date: Not specified
Modification Date: Not specified
Keywords: Acute diarrhea, fixed dose combination, metronidazole, mixed gastrointestinal infection, rifaximin
Context: A clinical study evaluating the efficacy and safety of a fixed-dose combination of rifaximin and metronidazole for treating acute diarrhea.
Topics: vaginosis Metronidazole Trichomonas